We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > asthma

News List

FDA approves Fasenra for severe eosinophilic asthma europeanpharmaceuticalreview
November 17, 2017
The FDA has approved Fasenra for the add-on maintenance treatment of patients with severe asthma aged 12 years and older…
Singapore conducts research on asthma and COPD biospectrumasia
October 19, 2017
The $1.2 million study aims to create a database for research into respiratory diseases.
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines b3cnewswire
October 10, 2017
OncoArendi Therapeutics announced today that this week the Company will initiate a Phase 1 study designed to assess the safety
GSK files for extended use of Relvar Ellipta in asthma pharmatimes
July 25, 2017
GlaxoSmithKline and Innoviva have applied in Europe to market Relvar Ellipta for extended use in patients with asthma who are already adequately controlled on inhaled corticosteroid long-acting β2-agonist therapy.